Genfit SA: Lead program Elafibranor is PPAR alpha/delta agonist in Ph 3 for NASH with data expected by YE 2019. Announced positive ph 2 PBC data in Dec 2018. Announced NASH biomarker diagnostic program; signed licensing agreement with LabCorp.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase III
Disease Space
Anti-inflammatory, Metabolic Disorders
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
500MM +
Therapeutic Modalities
Small Molecule
Website:
Address:
245, First Street, 18th Floor
Cambridge, MA 02142
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Hamptons CEO Roundtable 2019

Bridgehampton, August 15, 2019

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.